Trauma & Joint replacement.

Taragenyx has developed a point-of-care spray therapy for the treatment of implant related infection, pain and thrombosis.

POST-OPERATIVE TREATMENTS FOR INFECTION, PAIN, & THROMBOSIS

The use of antibiotics, opioid analgesics and anti-thrombotic agents all have well established risks. Therefore a new approach to surgical management could produce an opportunity to enhance both patient comfort and any post-operative complications associated with implant replacement or fracture surgery.

TRGYX-002 utilises a novel drug-elution and delivery technology to safely and accurately deliver therapeutic medications directly to an implant site to reduce infection, pain, and the incidence of thrombosis.

The medication can be delivered directly either as a therapeutic spray or combined with existing implant designs to deliver accurate clinical doses as a therapeutic drug-device combination product.

PRODUCT FEATURES

Prophylactic Treatment: Post-operative delivery of therapeutic agents for pain and infection.

Tuneable Effect: Drug release properties can be tuned to 1, 3, 5 or even 28 days duration.

Adaptable: Elution technology can be adapted due a wide spectrum of therapeutic drug candidates.

Tx